Garry M Carbone, MD | |
281 N 12th St Ste C, Lehighton, PA 18235-1101 | |
(610) 379-4740 | |
(610) 379-4745 |
Full Name | Garry M Carbone |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 33 Years |
Location | 281 N 12th St Ste C, Lehighton, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578512299 | NPI | - | NPPES |
0012379820008 | Medicaid | PA | |
02867700 | Other | PA | CAPITAL BLUE CROSS |
710518 | Other | PA | HIGHMARK BLUE SHIELD |
110108413 | Other | PA | PALMETTO GBA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | MD043165L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lifespring In Home Care Of Eastern Pa | Whitehall, PA | Home health agency |
Bayada Home Health Care, Inc. | Bethlehem, PA | Home health agency |
Ascend Hospice | Fort washington, PA | Hospice |
St Luke's Hospice | Bethlehem, PA | Hospice |
St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
St Luke's Miners Memorial Hospital | Coaldale, PA | Hospital |
Reading Hospital | West reading, PA | Hospital |
Entity Name | Garry M Carbone Md Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679693857 PECOS PAC ID: 0143608927 Enrollment ID: O20220607002058 |
News Archive
OrbusNeich today announced at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 in Washington the completion of patient enrollment in the randomized clinical trial of the Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) with 183 patients included at sites in Asia, Australia, Europe and South America.
Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its results for the second quarter ended June 30, 2012.
The newest guidelines for the use of cholesterol-lowering statins in people at risk of heart disease may be too generic, excluding middle-aged adults who could benefit from the drugs, and over-prescribing in older adults, according to a new study from the Duke Clinical Research Institute.
The research was conducted over a period of six months with a group of 36 patients in the Hemodialysis Unit of the General University Hospital of Alicante and three nurses who had received training in solution-focused communication.
Roche NimbleGen announces that Southern California (Aliso Viejo) based genomic services provider Ambry Genetics has officially become a Certified Service Provider (CSP) for the NimbleGen SeqCap EZ Exome workflow. They will provide target-enrichment services using NimbleGen SeqCap EZ Human Exome coupled with next-generation sequencing services for genetic research.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Garry M Carbone, MD 281 N 12th St Ste C, Lehighton, PA 18235-1101 Ph: (610) 379-4740 | Garry M Carbone, MD 281 N 12th St Ste C, Lehighton, PA 18235-1101 Ph: (610) 379-4740 |
News Archive
OrbusNeich today announced at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 in Washington the completion of patient enrollment in the randomized clinical trial of the Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) with 183 patients included at sites in Asia, Australia, Europe and South America.
Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its results for the second quarter ended June 30, 2012.
The newest guidelines for the use of cholesterol-lowering statins in people at risk of heart disease may be too generic, excluding middle-aged adults who could benefit from the drugs, and over-prescribing in older adults, according to a new study from the Duke Clinical Research Institute.
The research was conducted over a period of six months with a group of 36 patients in the Hemodialysis Unit of the General University Hospital of Alicante and three nurses who had received training in solution-focused communication.
Roche NimbleGen announces that Southern California (Aliso Viejo) based genomic services provider Ambry Genetics has officially become a Certified Service Provider (CSP) for the NimbleGen SeqCap EZ Exome workflow. They will provide target-enrichment services using NimbleGen SeqCap EZ Human Exome coupled with next-generation sequencing services for genetic research.
› Verified 4 days ago
Dr. Hasan Bayat, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 211 N 12th St, Lehighton, PA 18235 Phone: 610-377-7174 Fax: 610-377-4785 | |
Dr. Tatyana Pankratova, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2128 Blakeslee Boulevard Dr E, Lehighton, PA 18235 Phone: 610-402-5369 | |
Dr. Harry T Berger, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 281 N 12th St, Suite B, Lehighton, PA 18235 Phone: 610-377-7793 Fax: 610-377-9241 | |
Dr. Todd Richard Banning, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1241 Blakeslee Boulevard Dr E, Lehighton, PA 18235 Phone: 570-386-6900 Fax: 570-386-6901 | |
Andrew E Schwartz, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 204 State Rd, Lehighton, PA 18235 Phone: 610-379-0443 Fax: 610-379-4725 | |
Robert A Durako, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1001 Mahoning St, Lehighton, PA 18235 Phone: 610-379-0200 Fax: 610-379-0216 | |
William M Markson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1241 Blakeslee Boulevard Dr E, Lehighton, PA 18235 Phone: 570-386-6900 Fax: 570-386-6901 |